Associated Papers
Longitudinal ultra-sensitive mutation burden sequencing for precise minimal residual disease assessment in AML.
Wu Y et al.
Nature Communications, 2024
39543210 (PubMed )
Supplement: 41467_2024_54254_MOESM4_ESM.xlsx › No.14
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Sargas C et al.
Haematologica, 2021
Identification of two novel NPM1 mutations in patients with acute myeloid leukemia.
Jeon Y et al.
Annals of Laboratory Medicine, 2013
Select a paper to view details